GZMH and lipodystrophy: Therefore, our previous findings (Mcilroy et al., 2018a,b), along with those presented in this paper, would imply that these and other small additional residual adipose tissue depots that remain may be sufficient to prevent the development of metabolic dysfunction associated with lipodystrophy in CGL2.